| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |